Drug Shortage Report for ZOSTAVAX II
| Report ID | 5237 |
| Drug Identification Number | 02375516 |
| Brand name | ZOSTAVAX II |
| Common or Proper name | (zoster vaccine live, attenuated [Oka/Merck], refrigerator-stable) powder for suspension for injection |
| Company Name | MERCK CANADA INC |
| Market Status | CANCELLED POST MARKET |
| Active Ingredient(s) | VARICELLA-ZOSTER VIRUS VACCINE LIVE ATTENUATED |
| Strength(s) | 19400PFU |
| Dosage form(s) | POWDER FOR SUSPENSION |
| Route of administration | SUBCUTANEOUS |
| Packaging size | 1 Dose Vial |
| ATC code | J07BK |
| ATC description | VIRAL VACCINES |
| Reason for shortage | Demand increase for the drug. |
| Anticipated start date | 2017-05-25 |
| Actual start date | |
| Estimated end date | 2017-06-16 |
| Actual end date | 2017-05-17 |
| Shortage status | Avoided shortage |
| Updated date | 2017-05-17 |
| Company comments | Shortage Avoided |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | 16750 ROUTE TRANSCANADIENNE KIRKLAND, QUEBEC CANADA H9H 4M7 |
| Company contact information | 1-800-567-2594 medinfocanada@merck.com |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
| Version Number | Date Updated | Language | |
|---|---|---|---|
| v1 | 2017-04-03 | English | Compare |
| v2 | 2017-04-03 | English | Compare |
| v3 | 2017-04-03 | English | Compare |
| v4 | 2017-04-03 | English | Compare |
| v5 | 2017-04-03 | French | Compare |
| v6 | 2017-05-17 | English | Compare |
| v7 | 2017-05-17 | French | Compare |
Showing 1 to 7 of 7